Article info

Download PDFPDF
Antitumor activity of irofulven against human ovarian cancer cell lines, human tumor colony-forming units, and xenografts

Authors

  1. Address correspondence and reprint requests to: Emily S. Van Laar, MGI Pharma, Inc, 5775 West Old Shakopee Road, Suite 100, Bloomington, MN 55437-3174. Email: evanlaar{at}mgipharma.com

Citation

Van Laar ES, Izbicka E, Weitman S, et al
Antitumor activity of irofulven against human ovarian cancer cell lines, human tumor colony-forming units, and xenografts

Publication history

  • First published August 1, 2004.
Online issue publication 
March 06, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.